FDA Panel Pushes For Approval Of Amgen's Cholesterol-Lowering Drug Repatha Members of an FDA panel urge the agency to approve Repatha. The drug made by Amgen is said to significantly lower LDL or "bad" cholesterol. by Rina Marie Doctor